列表:病毒学 知网目次 | 5 条记录 |
1 Virology《病毒学》(官网投稿)
复合影响因子:0.0000,收录:知网目次 ,英语
Virology《病毒学》(月刊). Virology publishes papers that provide advances to the understanding of virus biology. We have been publishing the results of basic research in all branches of virology for over 60 years. The journal welcomes submissions on virus replication, virus-host biology, viral pathogenesis, immunity to viruses, virus structure, and virus evolution and ecology.
2 Antiviral Research《抗病毒研究》(官网投稿)
复合影响因子:0.0000,收录:知网目次 ,英语
Antiviral Research《抗病毒研究》(月刊). Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals.
复合影响因子:0.0000,收录:知网目次 ,英语
Annual Review of Virology《病毒学年评》(年刊). AIMS AND SCOPE OF JOURNAL: The Annual Review of Virology communicates exciting advances in our understanding of viruses of animals, plants, bacteria, archaea, fungi, and protozoa. Reviews highlight new ideas and directions in basic virology, viral disease mechanisms, virus-host interactions, and cellular and immune responses to virus infection, and reinforce the position of viruses as uniquely powerful probes of cellular function.
4 AIDS《艾滋病》(官网投稿)
复合影响因子:0.0000,收录:知网目次,维普目次 ,英语
AIDS《艾滋病》(一年15期). Publishing the very latest ground breaking research on HIV and AIDS. Read by all the top clinicians and researchers, AIDS has the highest impact of all AIDS-related journals.
复合影响因子:0.0000,收录:知网目次,维普目次 ,英语
AIDS Research and Human Retroviruses《艾滋病研究和人体逆转录酶病毒》(月刊). AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS. The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research, focusing on developments in prevention science, novel therapeutics, and immune-restorative approaches. Cutting-edge papers on the latest progress and research advances through clinical trials and examination of targeted antiretroviral agents lead to improvements in translational medicine for optimal treatment outcomes.